Table 2.
Number of cases of 47 diseases and disease durations at the time of entry in the BioBank Japan Project.
| Disease group | Disease name | Number of cases (with serum) | Median disease duration at entry (interquartile range, years) | ||
|---|---|---|---|---|---|
| Malignant tumors | Lung cancer | 3779 | (3777) | 0.7 | (0.2–2.9) |
| Esophageal cancer | 1291 | (1290) | 0.4 | (0.2–2.8) | |
| Gastric cancer | 6322 | (6316) | 1.0 | (0.2–4.0) | |
| Colorectal cancer | 6759 | (6754) | 1.0 | (0.2–3.4) | |
| Liver cancer | 1924 | (1922) | 1.2 | (0.3–3.3) | |
| Pancreas cancer | 392 | (392) | 0.4 | (0.1–1.5) | |
| Gallbladder/Cholangiocarcinoma | 392 | (393) | 0.5 | (0.2–2.1) | |
| Prostate cancer | 5066 | (5065) | 1.0 | (0.3–2.8) | |
| Breast cancer | 6336 | (6336) | 0.8 | (0.2–3.6) | |
| Cervical cancer | 1218 | (1218) | 1.8 | (0.4–5.3) | |
| Uterine cancer | 1026 | (1026) | 1.5 | (0.4–4.4) | |
| Ovarian cancer | 888 | (888) | 1.8 | (0.5–4.9) | |
| Hematopoietic tumor | 1307 | (1303) | 2.4 | (0.9–5.1) | |
| Cerebral diseases | Cerebral infarction | 16,534 | (16,522) | 2.2 | (0.4–5.6) |
| Cerebral aneurysm | 2710 | (2709) | N/A | ||
| Epilepsy | 2303 | (2275) | 5.6 | (1.7–13.4) | |
| Respiratory diseases | Bronchial asthma | 8700 | (8642) | 9.0 | (3.0–20.0) |
| Pulmonary tuberculosis | 863 | (862) | N/A | ||
| Chronic obstructive pulmonary diseasea | 2774 | (2771) | 3.0 | (1.0–8.0) | |
| Interstitial lung disease/Pulmonary fibrosis | 808 | (804) | 3.0 | (1.0–7.0) | |
| Cardiovascular diseases | Myocardial infarction | 13,272 | (13,270) | 3.8 | (0.7–8.7) |
| Unstable anginaa | 4330 | (4324) | 2.6 | (0.5–6.4) | |
| Stable anginaa | 14,807 | (14,800) | 3.6 | (1.0–7.9) | |
| Arrhythmiaa | 15,912 | (15,905) | 3.7 | (1.1–8.3) | |
| Heart failurea | 7610 | (7601) | 1.9 | (0.4–5.4) | |
| Peripheral arterial diseases | 2683 | (2679) | N/A | ||
| Liver diseases | Chronic hepatitis B | 1346 | (1345) | N/A | |
| Chronic hepatitis C | 5819 | (5817) | N/A | ||
| Liver cirrhosis | 2519 | (2509) | N/A | ||
| Urologic diseases | Nephrotic syndrome | 1056 | (1007) | N/A | |
| Urolithiasis | 6307 | (6306) | N/A | ||
| Metabolic diseases | Osteoporosis | 6743 | (6739) | N/A | |
| Diabetes mellitusb | 39,697 | (39,686) | 6.0 | (2.0–12.0) | |
| Dyslipidemiab | 43,812 | (43,787) | 3.0 | (1.0–7.0) | |
| Endocrine diseases | Graves' disease | 2323 | (2322) | N/A | |
| Connective tissue diseases | Rheumatoid arthritis | 4139 | (4139) | 7.7 | (2.6–15.3) |
| Allergic diseases | Hay fever | 5658 | (5645) | N/A | |
| Dermatologic diseases | Drug eruption | 585 | (586) | N/A | |
| Atopic dermatitisa | 2938 | (2896) | 16.0 | (5.0–25.0) | |
| Keloid | 809 | (808) | N/A | ||
| Gynecologic diseases | Uterine fibroid | 5904 | (5902) | N/A | |
| Endometriosis | 1843 | (1843) | N/A | ||
| Pediatric diseases | Febrile seizure | 333 | (275) | N/A | |
| Ophthalmologic diseases | Glaucoma | 4755 | (4753) | 3.6 | (1.1–8.2) |
| Cataract | 20,002 | (19,988) | 1.5 | (0.2–5.4) | |
| Dental diseases | Periodontitis | 3898 | (3896) | 0.1 | (0.0–1.7) |
| Other | Amyotrophic lateral sclerosisa | 782 | (771) | 4.0 | (2.1–6.9) |
Abbreviation: N/A, not available.
a
The duration of disease was calculated based on the time of disease onset to the time of entry into the registry.
b
Because we surveyed calendar year of diagnosis for these diseases, the periods from diagnosis were not measured in units of days and months.